Breaking
FDA approves GSK’s bepirovirsen for chronic hepatitis B
Field Reports

FDA approves GSK’s bepirovirsen for chronic hepatitis B

Syuhada Zulkifli · 29/10/2026

On October 20, the FDA cleared bepirovirsen, marketed as Hibsago, for use in adults battling chronic hepatitis B virus (HBV). This drug, created by GSK,.

★

Crisis Cams

Crisis Cams →
Liver disease MASH detection and treatment advances
Crisis Cams

Liver disease MASH detection and treatment advances

Doctors diagnose metabolic dysfunction-associated steatohepatitis (MASH) through blood tests and imaging, and explore emerging treatment options fo

+

More News

FDA approves GSK’s bepirovirsen for chronic hepatitis B
Field Reports

On October 20, the FDA cleared bepirovirsen, marketed as Hibsago, for use in adults battling chronic hepatitis B…

29/10/2026
SAMHSA raises first-day methadone dose for fentanyl users
Aid Ops

Methadone remains a cornerstone for opioid use disorder, yet the rise of illicit fentanyl has altered the patient…

28/10/2026
Liver disease MASH detection and treatment advances
Crisis Cams

Doctors diagnose metabolic dysfunction-associated steatohepatitis (MASH) through blood tests and imaging, and explore emerging treatment options fo

27/10/2026
LLMs reveal hidden layers in chronic pain assessment
Live Outbreaks

New research shows large language models may uncover hidden dimensions in chronic pain assessment that traditional severity scales…

26/10/2026
New Medical Codes Take Effect January 1
Live Outbreaks

New medical codes take effect January 1, including updates to maternity care and speech therapy codes, one of…

25/10/2026
Physicians encouraged to adopt failure as learning tool
Aid Ops

Physicians encouraged to adopt failure as a learning tool to improve healthcare excellence.

24/10/2026
Alzheimer’s Group Aims to Improve Brain Care
Aid Ops

Alzheimer's group aims to improve brain care through standardizing dementia treatment and care pathways.

23/10/2026
New Treatments Emerge for Generalized Myasthenia Gravis
Live Outbreaks

New treatments for generalized myasthenia gravis that offer improved disease control and reduced corticosteroid side effects.

22/10/2026
Doximity and OpenEvidence settle AI dispute
Live Outbreaks

Doximity and OpenEvidence settle AI dispute over corporate spying allegations and fraudulent doctor identities.

21/10/2026
CMS proposes rule to fix provider directories
Health Streams

CMS proposes rule to fix provider directories for Medicare Advantage plans accurately.

20/10/2026